Biofarmacijos tyrimų laboratorija, UAB - financials and debts

Company age: 6 y. 11 mo.

Update

Biofarmacijos tyrimų laboratorija - Company finances

  • The company is late in submitting financial data for the previous financial year.
  • Latest financial data up to 2024-12-31.
EUR
2019
From: 2019-10-09
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
Financial data
Sales revenue - - - - 42,719 -
Profit before tax -309 -12,501 -8,104 -108,876 -84,992 -59,263
Net profit -309 -12,501 -8,104 -108,876 -84,992 -59,263
Equity 2,588 -9,913 -18,017 50,216 -34,776 -94,040
Liabilities 141 41,505 7,501 119,442 173,707 96,697
Non-current assets 0 0 0 94,426 9,003 21
Current assets 2,729 31,592 24,246 75,232 129,928 2,636
Total assets 2,729 31,592 24,246 169,658 138,931 2,657
Taxes paid
STI taxes - - - - 7,565 -
Financial indicators
Revenue change y/y - - - - - -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -11.3% -39.6% -33.4% -64.2% -61.2% -2230.4%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -11.9% - - -216.8% - -
Profit margin Net profit margin. Shows the overall profitability of the company. - - - - -199.0% -
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - -199.0% -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.1 - - 2.4 - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - 13,144 -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biofarmacijos tyrimų laboratorija - Social security debts

The amount of overdue SODRA debt for the company Biofarmacijos tyrimų laboratorija as of the last working day is: 8 €

From To Debt, €
2026-09-05 2026-09-14 8.20
2026-08-26 2026-09-02 8.20
2026-08-23 2026-08-23 8.20
2026-08-19 2026-08-19 8.20
2026-08-16 2026-08-17 8.20
2026-05-03 2026-08-14 8.20
2026-03-29 2026-04-30 8.20
2026-03-17 2026-03-27 8.20
2026-03-15 2026-03-15 8.20
2025-10-24 2026-03-11 8.20
2025-06-17 2025-07-20 33.98
2025-06-11 2025-06-16 9.71
2025-06-08 2025-06-09 9.71
2025-05-30 2025-06-04 9.71
2025-05-12 2025-05-14 76.42
2025-05-04 2025-05-11 1086.68
2025-04-16 2025-04-30 1086.68
2025-03-18 2025-04-15 1010.26
2025-03-04 2025-03-17 159.26
2025-03-03 2025-03-03 192.38
2025-02-27 2025-03-02 159.26
2025-02-24 2025-02-26 192.38
2025-02-18 2025-02-23 462.38
2025-02-10 2025-02-10 1.03
2025-01-22 2025-01-28 1.03
2024-10-16 2024-10-20 591.90
2023-10-30 2023-11-12 4.07
2023-10-25 2023-10-25 4.07
2023-05-24 2023-05-24 518.30
2023-05-16 2023-05-23 653.71
2022-08-29 2022-09-06 0.06
2022-08-23 2022-08-28 393.61
2022-07-18 2022-07-24 555.62

Biofarmacijos tyrimų laboratorija - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.